Electroconvulsivotherapy Augmentation With Folate in the Treatment of a Resistant Depression

被引:4
|
作者
Mouaffak, Fayal [1 ,2 ]
de Premorel, Alix [1 ]
Helali, Haifa [1 ,2 ]
Hardy, Patrick [1 ,2 ]
Hozer, Franz [1 ,2 ]
机构
[1] Bicetre Univ Hosp, Dept Psychiat, F-94270 Paris, France
[2] Univ Paris Sud, INSERM, AP HP, Paris, France
关键词
resistant depression; bariatric surgery; folate deficiency; DISORDERS;
D O I
10.1097/WNF.0000000000000048
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Depression is a severe and heterogeneous disorder resulting from interacting genetic, environmental, and epigenetic factors. Nutrient deficiency resulting from bariatric bypass surgery has been involved in the pathophysiological mechanisms of depression and treatment response. We report the case of a patient who developed, after a bariatric bypass surgery, a severe depressive episode, refractory to both pharmacological treatment and electroconvulsivotherapy (ECT). Folate deficiency was evidenced. A dramatic response to ECT was observed after folate supplementation. We focused on the involvement of folate in the pathophysiological mechanisms of depression and response to both pharmacological treatment and ECT. We emphasize on the need for close monitoring of patients experiencing psychiatric disorder (in particular, depressive unipolar disorder) after bariatric surgery.
引用
收藏
页码:158 / 159
页数:2
相关论文
共 50 条
  • [21] Augmentation strategies for treatment-resistant depression: a literature review
    Carvalho, A. F.
    Cavalcante, J. L.
    Castelo, M. S.
    Lima, M. C. O.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2007, 32 (05) : 415 - 428
  • [22] Quetiapine augmentation in treatment-resistant depression: a naturalistic study
    Marina Šagud
    Alma Mihaljević-Peleš
    Dorotea Mück-Šeler
    Miro Jakovljević
    Nela Pivac
    Psychopharmacology, 2006, 187 : 511 - 514
  • [23] Improvement in quality of life with risperidone augmentation in treatment resistant depression
    Walling, D
    Rupnow, MF
    Canuso, C
    Turkoz, I
    Gharabawi, G
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S163 - S163
  • [24] Antiinflammatory Augmentation Strategy Reverses Treatment Resistant Bipolar Depression
    Halaris, Angelos
    BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 297S - 297S
  • [25] Quetiapine augmentation in treatment-resistant depression:: a naturalistic study
    Sagud, Marina
    Mihaljevic-Peles, Alma
    Muck-Seler, Dorotea
    Jakovljevic, Miro
    Pivac, Nela
    PSYCHOPHARMACOLOGY, 2006, 187 (04) : 511 - 514
  • [26] Lamotrigine augmentation strategy for patients with treatment-resistant depression
    Gutierrez, RL
    McKercher, R
    Galea, J
    Jamison, KL
    CNS SPECTRUMS, 2005, 10 (10) : 800 - +
  • [27] Amantadine as augmentation therapy in the management of treatment-resistant depression
    Stryjer, R
    Strous, RD
    Shaked, G
    Bar, F
    Feldman, B
    Kotler, M
    Polak, L
    Rosenzcwaig, S
    Weizman, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2003, 18 (02) : 93 - 96
  • [28] Aripiprazole augmentation of tranylcypromine in treatment-resistant major depression
    Goforth, Harold W.
    Carroll, Brendan T.
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2007, 27 (02) : 216 - 217
  • [29] Predictors of efficacy in lithium augmentation for treatment-resistant depression
    Sugawara, Hiroko
    Sakamoto, Kaoru
    Harada, Tsuyoto
    Ishigooka, Jun
    JOURNAL OF AFFECTIVE DISORDERS, 2010, 125 (1-3) : 165 - 168
  • [30] Risperidone augmentation on resistant depression
    Young, A
    Rouillon, F
    Canuso, C
    Bossie, C
    Gharabawi, G
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S323 - S323